Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 38.57 |
| Open | 38.76 |
| Bid | 38.75 x 200 |
| Ask | 38.82 x 100 |
| Day's range | 38.56 - 39.38 |
| 52-week range | 29.85 - 45.00 |
| Volume | |
| Avg. volume | 1,013,680 |
| Market cap | 4.926B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 18.46 |
| EPS (TTM) | 2.10 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 51.11 |
PR NewswireMahesh Krishnan Elected to Halozyme's Board of Directors
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services.
ZacksWhy Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ZacksWhy This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.